首页 › 基金 › DEERFIELD MANAGEMENT COMPANY, L.P. › PHVS
DEERFIELD MANAGEMENT COMPANY, L.P. 对 PHVS 的持仓历史
PHARVARIS N V · 医疗保健
DEERFIELD MANAGEMENT COMPANY, L.P. 在 Q2 2026 的 13F 申报中披露持有 PHVS(PHARVARIS N V)3,376,042 股,市值约 US$116.7M,约占其申报组合的 1.46%,在其申报持仓中市值排名第 17 位。 DEERFIELD MANAGEMENT COMPANY, L.P. 最近 11 个申报季度中有 11 个季度披露了 PHVS 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P. 对 PHVS 的持仓演变
DEERFIELD MANAGEMENT COMPANY, L.P. 于 Q4 2023 首次披露 PHVS 持仓:812,236 股(约 US$22.8M)。 该持仓在 Q2 2026 达到峰值 3,376,042 股,市值约 US$116.7M。 在 11 次申报中,DEERFIELD MANAGEMENT COMPANY, L.P. 6 次增持、1 次减持、3 次保持不变。 最近一期申报(Q2 2026)显示持股 3,376,042 股、市值约 US$116.7M,环比增持 250,000 股。。 持仓曾出现大幅变动:Q1 2024 增持约 31%、Q2 2024 增持约 32% (随后一个季度股价上涨 2%)、Q3 2024 增持约 45%。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 812.24K | $22.78M | 新进 |
| Q1 2024 | 1.06M | $24.53M | 增持 |
| Q2 2024 | 1.40M | $26.27M | 增持 |
| Q3 2024 | 2.03M | $37.63M | 增持 |
| Q4 2024 | 2.02M | $38.67M | 减持 |
| Q1 2025 | 2.02M | $31.67M | 持有 |
| Q2 2025 | 2.02M | $35.51M | 持有 |
| Q3 2025 | 2.44M | $60.94M | 增持 |
| Q4 2025 | 3.13M | $86.75M | 增持 |
| Q1 2026 | 3.13M | $88.31M | 持有 |
| Q2 2026 | 3.38M | $116.74M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PHVS 与 13F 数据
PHVS(PHARVARIS N V)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 PHVS,申报仓位最大的包括:GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PHVS 的基金
- GENERAL ATLANTIC, L.P. 6.55M 股 · $226.53M · Q2 2026
- Foresite Capital Management IV, LLC 4.78M 股 · $165.24M · Q2 2026
- venBio Partners LLC 4.64M 股 · $160.57M · Q2 2026
- EQT Fund Management S.a r.l. 3.42M 股 · $118.42M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.68M 股 · $92.52M · Q2 2026
- Commodore Capital LP 1.43M 股 · $49.28M · Q2 2026
- Novo Holdings A/S 1.40M 股 · $48.41M · Q2 2026
- Saturn V Capital Management LP 1.31M 股 · $45.44M · Q2 2026
- TCG Crossover Management, LLC 1.01M 股 · $34.86M · Q2 2026
- Sofinnova Investments, Inc. 881.30K 股 · $30.48M · Q2 2026
- 5AM Venture Management, LLC 797.60K 股 · $27.58M · Q2 2026
- Seven Fleet Capital Management LP 774.50K 股 · $26.78M · Q2 2026
更多关于 DEERFIELD MANAGEMENT COMPANY, L.P.
常见问题
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held PHVS?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in PHVS?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 3.38M shares of PHVS (PHARVARIS N V), valued at $116.74M, representing 1.46% of its reported portfolio and ranking #17.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling PHVS?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in PHVS. The position peaked in Q2 2026 at 3.38M shares.
Which other funds hold PHVS?
Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.